Location History:
- Helsinki, FI (2000 - 2004)
- Boston, MA (US) (2001 - 2012)
- Brookline, MA (US) (2014)
Company Filing History:
4 out of 19 
2 out of 22 
1 out of 15 
Years Active: 2000-2014
Title: The Innovative Mind of Vladimir Joukov in Biomedicine
Introduction: Vladimir Joukov, a distinguished inventor based in Boston, MA, is renowned for his contributions to the field of biomedicine. With an impressive portfolio consisting of 16 patents, Joukov has made significant advancements that hold promise for therapeutic applications and biological research. His inventive spirit has propelled the understanding of vascular biology, particularly through his groundbreaking work on vascular endothelial growth factor C (VEGF-C).
Latest Patents: Among his latest patents, Joukov's work on the vascular endothelial growth factor C (VEGF-C) protein and gene stands out. This invention encompasses purified and isolated VEGF-C polypeptides designed to bind to KDR receptor tyrosine kinase (VEGFR-2) and Flt4 receptor tyrosine kinase (VEGFR-3). His innovation includes not only analogs of these peptides that exhibit VEGF-C-like or VEGF-like biological activities but also those that serve as inhibitors. Additionally, the patents cover polynucleotides encoding these polypeptides, as well as vectors and host cells. Pharmaceutical compositions and diagnostic reagents derived from these polypeptides, along with methods for making and utilizing them, are integral components of his latest research. Furthermore, he provides methods for inhibiting endothelial cell proliferation, showcasing his commitment to advancing vascular therapies.
Career Highlights: With a career grounded in scientific excellence, Vladimir Joukov has worked with various organizations, contributing his expertise in biomedical innovations. His prolific invention record reflects a deep understanding of molecular processes that pave the way for potential medical applications. Each patent he develops serves as a testament to his innovative approach toward solving complex biological challenges.
Collaborations: Joukov has collaborated with notable figures in the field, including Kari Alitalo, further enhancing his research impact. Their partnership reflects a shared vision of advancing understanding in vascular biology and deriving practical solutions for medical challenges.
Conclusion: Vladimir Joukov's work represents a significant contribution to the field of biomedicine, particularly through his latest patents concerning VEGF-C. His innovative spirit and collaborative efforts continue to inspire advancements that could profoundly influence therapeutic practices. As a leading inventor, Joukov's work exemplifies the importance of innovation in addressing health-related challenges, underscoring the vital role of inventors in driving scientific progress.